Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma

Nom de la revue
Rosario Aschero, Jasmine H. Francis, Daiana Ganiewich, Soledad Gomez-Gonzalez, Claudia Sampor, Santiago Zugbi, Daniela Ottaviani, Lauriane Lemelle, Marcela Mena, Ursula Winter, Genoveva Correa Llano, Gabriela Lamas, Fabiana Lubieniecki, Irene Szijan, Jaume Mora, Osvaldo Podhajcer, François Doz, François Radvanyi, David H. Abramson, Andrea S. Llera, Paula S. Schaiquevich, Cinzia Lavarino, Guillermo L. Chantada

Most reports about copy number alterations (CNA) in retinoblastoma relate to patients with intraocular disease and features of children with extraocular relapse remain unknown, so we aimed to describe the CNA in this population. We evaluated 23 patients and 27 specimens from 4 centers. Seventeen cases had extraocular relapse after initial enucleation and six cases after an initial preservation attempt. We performed an analysis of CNA and BCOR gene alteration by SNP array (Single Nucleotide Polymorfism array), whole-exome sequencing, IMPACT panel and CGH array (Array-based comparative genomic hybridization). All cases presented CNA at a higher prevalence than those reported in previously published studies for intraocular cases. CNA previously reported for intraocular retinoblastoma were found at a high frequency in our cohort: gains in 1q (69.5%), 2p (60.9%) and 6p (86.9%), and 16q loss (78.2%). Other, previously less-recognized, CNA were found including loss of 11q (34.8%), gain of 17q (56.5%), loss of 19q (30.4%) and BCOR alterations were present in 72.7% of our cases. A high number of CNA including 11q deletions, 17q gains, 19q loss, and BCOR alterations, are more common in extraocular retinoblastoma. Identification of these features may be correlated with a more aggressive tumor warranting consideration for patient management.